Product Program year 2025 Source: CMS Open Payments

Skyla

Drug Womens Health

NDC 50419-422-01

Open in the dashboard

General payments

$195,911

8,464 payments

Research payments

$98,810

6 payments

Through program year 2025, $195,911 in general payments and $98,810 in research payments were reported against Skyla (Womens Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $43,269 1,866
2024 General $33,823 1,614
2023 General $63,813 2,981
2023 Research $30,000 2
2022 General $55,006 2,003
2022 Research $68,810 4

Breakdown

Who paid General payments · program years 2022–2025
  1. Bayer HealthCare Pharmaceuticals Inc. $195,911 8,464 payments
Top recipients General payments · program year 2025
  1. Brent Davidson Obstetrics & Gynecology · Detroit, MI $1,750 4% · 5 payments
  2. Samir Ahuja Obstetrics & Gynecology · Mentor, OH $1,400 3% · 4 payments
  3. Mark Hathaway Obstetrics & Gynecology · Washington, DC $1,400 3% · 4 payments
  4. Jay Fisher Obstetrics & Gynecology · West Bloomfield, MI $700 2% · 2 payments
  5. Paula Castano Gynecology · New York, NY $700 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $24,910 59% · 799 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $3,858 9% · 159 practitioners
  3. Nurse Practitioner, Women's Health Nurse Practitioner $2,511 6% · 107 practitioners
  4. Advanced Practice Midwife $2,184 5% · 97 practitioners
  5. Gynecology Obstetrics & Gynecology $1,805 4% · 42 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $4,763 11% · 146 recipients
  2. Michigan $3,086 7% · 34 recipients
  3. Georgia $3,080 7% · 156 recipients
  4. Florida $2,717 6% · 120 recipients
  5. New York $2,628 6% · 75 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

8,464 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record